Imunon (IMNN) Interest Coverage Ratio (2010 - 2026)
Imunon's (IMNN) quarterly Interest Coverage Ratio came in at 35.48 in Q1 2026, down 41.42% YoY from 60.56 in Q1 2025, and up 1.47% on a QoQ basis from 36.01 in Q4 2025.
Imunon (IMNN) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Imunon (IMNN) has 17 years of Interest Coverage Ratio data on file, last reported at 35.48 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 41.42% year-over-year to 35.48 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 27.27 (up 53.52% YoY) and the FY2025 annual result came in at 0.19, up 97.99% from the prior year.
- Interest Coverage Ratio grew to 35.48 in Q1 2026, from 36.01 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 38.58 in Q4 2023 to a low of 40.95 in Q3 2022.
- A 5-year average of 22.03 and a median of 29.98 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio soared 2548.99% — and 2024, when it slumped 177.72%.
- Tracing IMNN's Interest Coverage Ratio over 5 years: stood at 1.58 in 2022, then soared by 2548.99% to 38.58 in 2023, then sank by 177.72% to 29.98 in 2024, then slipped by 20.08% to 36.01 in 2025, then increased by 1.47% to 35.48 in 2026.
- The last three Interest Coverage Ratio figures came in at 35.48 (Q1 2026), 36.01 (Q4 2025), and 22.46 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 1.42 |
| 10 | Imunon | 8.53 Mn | 8.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.48 |
| Dec 31, 2025 | -36.01 |
| Sep 30, 2025 | -22.46 |
| Jun 30, 2025 | -2.01 |
| Mar 31, 2025 | -25.09 |
| Dec 31, 2024 | -29.98 |
| Sep 30, 2024 | -13.40 |
| Jun 30, 2024 | -13.54 |
| Mar 31, 2024 | -30.83 |
| Dec 31, 2023 | 38.58 |
| Sep 30, 2023 | -19.81 |
| Jun 30, 2023 | -31.51 |
| Mar 31, 2023 | -31.66 |
| Dec 31, 2022 | -1.58 |
| Sep 30, 2022 | -40.95 |
| Jun 30, 2022 | -39.76 |
| Mar 31, 2022 | -39.06 |
| Dec 31, 2021 | 105.74 |
| Sep 30, 2021 | -33.94 |
| Jun 30, 2021 | -22.92 |